← Eichor
Condition: Serious Adverse Events Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Serious Adverse Events

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Chemokeyp: A Feasibility Study for Realtime Safety Data-Capture for Potential Serious Adverse Drug Events
Phase N/A · 1 location(s) · St Vincent's University Hospital, Ireland · NCT07592234
Safety and Performance Evaluation of CPB Venous and Arterial Cannulas
NA · 1 location(s) · Eurosets S.r.l. · NCT07354841
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06283927
V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency
Phase 3 · 1 location(s) · On Pharma Importadora, Exportadora e Distribuidora de Medica · NCT06954441
Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients wit
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT06607471
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
NA · 2 location(s) · University of Central Florida · NCT05838638
Tezspire Cardiac Events PASS
Phase N/A · 4 location(s) · AstraZeneca · NCT06951867
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.